Evaluation of a method for activity estimation in Sm-153 EDTMP imaging

Medical Physics

Volumn 36, Issue 4, 2009, Pages 1219-1229

  Vanzi, Eleonora ^a   Genovesi, Dario ^b   Di Martino, Fabio ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

D REGION; IMAGE SEGMENTATION; MUSCULOSKELETAL SYSTEM; PATHOLOGY; PHANTOMS; RADIOISOTOPES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

ACCURACY AND PRECISION; ACTIVITY EVALUATIONS; ACTIVITY QUANTIFICATION; ANTERIOR POSTERIORS; CONCENTRATION VALUES; PARTIAL VOLUME EFFECT; PLANNING STRATEGIES; QUANTIFICATION METHODS;

PATIENT TREATMENT;

LEXIDRONAM SAMARIUM SM 153;

ACCURACY; ARTICLE; BONE METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTROLLED STUDY; ERROR; GEOMETRY; PERFORMANCE; PHANTOM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIMULATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKELETON;

ALGORITHMS; COMPUTER SIMULATION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; NEOPLASM METASTASIS; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; PATTERN RECOGNITION, AUTOMATED; PHANTOMS, IMAGING; RADIOISOTOPES; RADIOMETRY; REPRODUCIBILITY OF RESULTS; SAMARIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 63849083668     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3089788     Document Type: Article

References (30)

1. W. F. Goeckeler, B. Edwards, W. A. Volkert, R. A. Holmes, J. Simon, and D. Wilson, " Skeletal localization of samarium-153 chelates: Potential therapeutic bone agents.," J. Nucl. Med. 28, 495-504 (1987).
2. C. Collins, J. F. Eary, G. Donaldson, C. Vernon, N. E. Bush, S. Petersdorf, R. B. Livingston, E. E. Gordon, C. R. Chapman, and F. R. Appelbaum, " Samarium 153-EDTMP in bone metastases of hormone refractory prostate carcinoma: A phase I/II trial.," J. Nucl. Med. 34, 1839-1844 (1993).
3. J. H. Turner and P. G. Claringbold, " A phase II study of treatment of painful multifocal skeletal metastasis with single and repeated dose samarium-153 ethylendiaminetetramethylene phosphonate.," Eur. J. Cancer 27, 1084-1086 (1991).
4. I. Resche, J. F. Chantal, A. Pecking, P. Ell, G. Duchesne, R. Rubens, I. Fogelman, S. Houston, A. Fauser, M. Fischer, and D. Wilkins, " A dose-controlled study of Sm-153-EDTMP with painful bone metastasis.," Eur. J. Cancer 33, 1583-1591 (1997).
5. J. H. Tian, J. M. Zhang, Q. T. Hou, Q. H. Oyang, J. M. Wang, Z. S. Luan, L. Chuan, and Y. J. He, " Multi-center trial on the efficacy and toxicity of single dose samarium-153 ethylendiamine methylene phosphonate as a palliative treatment for painful skeletal metastasis in China.," Eur. J. Nucl. Med. 26, 2-7 (1999).
6. S. Ricci, G. Boni, I. Pastina, D. Genovesi, C. Cianci, S. Chiacchio, C. Orlandini, M. Grosso, A. AlSharif, A. Chioni, S. Donato, F. Francesca, C. Selli, D. Rubello, and G. Mariani, " Clinical benefit of bone-targeted radiometabolic therapy with Sm153 -EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer.," Eur. J. Nucl. Med. Mol. Imaging 34, 1023-1030 (2007).
7. G. Sgouros, " Dosimetry of internal emitters.," J. Nucl. Med. 46, 18S-27S (2005).
8. E. E. Watson, M. G. Stabin, and J. A. Siegel, " MIRD formulation.," Med. Phys. 20, 511-514 (1993).
9. L. Strigari, R. Sciuto, M. D'Andrea, R. Pasqualoni, M. Benassi, and C. L. Maini, " Radiopharmaceutical therapy for bone metastases with Sr89 Cl2, Re186 -HEDP and Sm153 -EDTMP: A dosimetric study using Monte Carlo simulation.," Eur. J. Nucl. Med. Mol. Imaging 34, 1031-1038 (2007).
10. G. Sgouros, G. Barest, J. Tekkumthala, C. Chui, R. Mohan, R. E. Bigler, and P. Zanzonico, " Treatment planning for internal radionuclide therapy: Three-dimensional dosimetry for nonuniformly distributed radionuclides.," J. Nucl. Med. 31, 1884-1891 (1990).
11. S. R. Thomas, H. R. Maxon, and J. G. Kereiakes, " In vivo quantitation of lesion radioactivity using external counting methods.," Med. Phys. 3, 253-255 (1976).
12. W. Brenner, W. U. Kampen, A. M. Kampen, and E. Henze, " Skeletal uptake and soft-tissue retention of Re186 -HEDP and Sm153 -EDTMP in patients with metastatic bone disease.," J. Nucl. Med. 42, 230-236 (2001).
13. A. J. van Rensburg, A. S. Alberts, and K. A. Louw, " Quantifying the radiation dosage to individual skeletal lesions treated with Samarium-153-EDTMP.," J. Nucl. Med. 39, 2110-2115 (1998).
14. J. F. Eary, C. Collins, M. Stabin, C. Vernon, S. Petersdorf, M. Baker, S. Hartnett, S. Frency, S. J. Addison, F. Appelbaum, and E. E. Gordon, " Samarium-153-EDTMP biodistribution and dosimetry estimation.," J. Nucl. Med. 34, 1031-1036 (1993).
15. H. B. Giap, D. J. Maccy, and D. A. Podoloff, " Development of a SPECT-based three-dimensional treatment planning system for radioimmunotherapy., " J. Nucl. Med. 36, 1885-1894 (1995).
16. K. F. Koral, Y. Dewaraya, J. Li, C. L. Barrett, D. D. Regan, K. R. Zasadny, S. G. Rommelfanger, I. R. Francis, M. S. Kaminski, and R. L. Wahl, " Initial results for hybrid SPECT-conjugate-view tumor dosimetry in 131I-anti-B1 antibody therapy of previously untreated patients with lymphoma.," J. Nucl. Med. 41, 1579-1586 (2000).
17. M. Ljungberg, K. Sjogreen, X. Liu, E. Frey, Y. Dewaraya, and S. E. Strand, " A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: Evaluation for 131I using Monte Carlo simulation.," J. Nucl. Med. 43, 1101-1109 (2002).
18. B. He, Y. Du, X. Song, W. P. Segars, and E. C. Frey, " A Monte Carlo and physical phantom evaluation of quantitative In-I11 SPECT.," Phys. Med. Biol. 50, 4169-4185 (2005).
19. P. B. Zanzonico, " Internal radionuclide radiation dosimetry: A review of basic concepts and recent developments.," J. Nucl. Med. 41, 297-308 (2000).
20. A. Liu, L. E. Williams, and A. A. Raubitschek, " A CT assisted method for absolute quantitation of internal radioactivity.," Med. Phys. 23, 1919-1928 (1996).
21. B. He and E. C. Frey, " Comparison of conventional, model-based quantitative planar, and quantitative SPECT image processing methods for organ activity estimamtion using In-111 agents.," Phys. Med. Biol. 51, 3967-3981 (2006).
22. A. R. Formiconi, " Least squares algorithm for region of interest evaluation in emission tomography.," IEEE Trans. Med. Imaging 12 (1), 90-100 (1993).
23. E. Vanzi, M. T. De Cristofaro, S. Ramat, B. Sotgia, M. Mascalchi, and A. R. Formiconi, " A direct ROI quantification method for inherent PVE correction: Accuracy assessment in striatal SPECT measurements.," Eur. J. Nucl. Med. Mol. Imaging 34, 1480-1489 (2007).
24. O. G. Rousset, Y. Ma, and A. C. Evans, " Correction for partial volume effects in PET: Principle and validation.," J. Nucl. Med. 39, 904-911 (1998).
25. H. M. Hudson and R. S. Larkin, " Accelerated image reconstruction using ordered subsets of projection data.," IEEE Trans. Med. Imaging 13, 601-609 (1994).
26. A. R. Formiconi, A. Passeri, and P. Calvini, " Theoretical determination of the collimator geometrical transfer function for the reconstruction of SPECT data.," IEEE Trans. Nucl. Sci. 46 (4), 1075-1080 (1999).
27. P. Boccacci, P. Bonetto, P. Calvini, and A. R. Formiconi, " A simple model for the efficient correction of collimator blur in 3D SPECT imaging.," Inverse Probl. 15, 907-930 (1999).
28. W. H. Press, S. A. Teukolsky, W. T. Vetterling, and B. P. Flannery, Numerical Recipes in C: The Art of Scientific Computing, 2nd ed. (Cambridge University Press, Cambridge, 1992).
29. EANM Guidelines for Treatment Of Refractory Metastatic Bone Pain (http://www.eanm.org/scientific-info/guidelines/gl-radio-treatment.php?navId=54) .
30. D. Utsunomiya, S. Shiraishi, M. Imuta, S. Tomiguchi, K. Kawanaka, S. Morishita, K. Awai, and Y. Yamashita, " Added value of SPECT/CT fusion in assessing suspected bone metastasis: Comparison with scintigraphy alone and nonfused scintigraphy and CT.," Radiology 238, 264-271 (2006).